During the past decade, McLaren Cancer Institute-Central Michigan conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 11 clinical trials were completed, i.e. on average, 29.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McLaren Cancer Institute-Central Michigan" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "NRG Oncology" with 9 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Cancer Institute-Central Michigan" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "McLaren Cancer Institute-Central Michigan" are "Stage II Breast Cancer" (5 trials), "Invasive Breast Carcinoma" (4 trials), "Stage IIIA Breast Cancer" (4 trials), "Colon Adenocarcinoma" (3 trials) and "Estrogen Receptor Negative" (3 trials). Many other conditions were trialed in "McLaren Cancer Institute-Central Michigan" in a lesser frequency.

Most popular intervention types in "McLaren Cancer Institute-Central Michigan" are "Drug" (34 trials), "Other" (28 trials), "Radiation" (17 trials), "Biological" (10 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (16 trials), "Laboratory Biomarker Analysis" (12 trials), "Fluorouracil" (8 trials), "Questionnaire Administration" (7 trials) and "Biospecimen Collection" (6 trials). Other intervention names were less common.

The vast majority of trials in "McLaren Cancer Institute-Central Michigan" are 36 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "McLaren Cancer Institute-Central Michigan". undefined are not yet recruiting, 12 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in McLaren Cancer Institute-Central Michigan, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in McLaren Cancer Institute-Central Michigan, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".